Intrinsiqs

Is Aquestive Therapeutics, Inc. overvalued?

Aquestive Therapeutics, Inc. (AQST) — key valuation metrics and fundamentals.

No verdict
Price
$3.91
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$491.4M
Dividend yield
0.0%
Return on equity
255.1%
Sector
Healthcare

See the full interactive analysis →

Fair value compares AQST's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.